Många läkemedel – både nya och gamla – sänker blodglukos - För att ge patienten optimal läkemedelsbehandling krävs kännedom om patofysiologi och verkningsmekanismer

Lakartidningen. 2018 Feb 20:115:EXDT.
[Article in Swedish]
No abstract available

MeSH terms

  • Algorithms
  • Anticholesteremic Agents / pharmacokinetics
  • Anticholesteremic Agents / therapeutic use*
  • Blood Glucose / drug effects*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Glycoside Hydrolase Inhibitors / pharmacokinetics
  • Glycoside Hydrolase Inhibitors / therapeutic use
  • Humans
  • Incretins / pharmacokinetics
  • Incretins / therapeutic use
  • Insulin / pharmacokinetics
  • Insulin / therapeutic use
  • Insulin Resistance / physiology
  • Life Style
  • Metformin / pharmacokinetics
  • Metformin / therapeutic use
  • Practice Guidelines as Topic
  • Sulfonylurea Compounds / pharmacokinetics
  • Sulfonylurea Compounds / therapeutic use

Substances

  • Anticholesteremic Agents
  • Blood Glucose
  • Glycoside Hydrolase Inhibitors
  • Incretins
  • Insulin
  • Sulfonylurea Compounds
  • Metformin